Hot Stocks To Buy For 2018

Free Preview

For full access, Log in or Subscribe Now and get 4 weeks free!

A difference that makes no difference is no difference.

This famous piece of advice, attributed to Star Treks Spock, among others, is particularly relevant to retirees and soon-to-be-retirees. Thats because many of the investment decisions that strike them as most urgent and crucial end up having surprisingly little impact on their retirement standard of living.

Hot Stocks To Buy For 2018: Vanguard Mega Cap Value ETF (MGV)

Advisors’ Opinion:

  • [By Todd Shriber, ETF Professor]

    Three of Vanguard's mega-cap equity ETFs now sport annual expense ratios of 0.07 percent, down from 0.09 percent. Those ETFs are the Vanguard Mega Cap ETF (NYSE: MGC), Vanguard Mega Cap 300 Growth Index ETF (NYSE: MGK) and the Vanguard Mega Cap Value Index ETF (NYSE: MGV).

Hot Stocks To Buy For 2018: Apricus Biosciences, Inc(APRI)

Advisors’ Opinion:

  • [By Jon C. Ogg]

    The biotechs and emerging pharma havebeen under pressure from politicians attacking drug prices. That doesn’t mean that there are not some big winners out there. Sometimes the biggest winners are companies most investors have never heard of. Even if you have been a biotech and emerging pharma investor for years, chances are high that you would have never heard of a small outfit called Apricus Biosciences Inc. (NASDAQ: APRI).

  • [By Chris Lange]

    Apricus Biosciences Inc. (NASDAQ: APRI) has a PDUFA goal date for completion of the FDAs review of the Vitaros NDA set on February 17. Vitaros is a novel, on-demand topical cream for the treatment of erectile dysfunction (ED) and a new potential entrant into the U.S. ED treatment market. So far Vitaros has been approved in Canada, Mexico and certain countries in Europe, Latin America and the Middle East. Shares of Apricus were last seen at $2.22, with a 52-week range of $0.86 to $3.49 and a consensus price target of $3.50.

  • [By William Romov]

    California-based Apricus Biosciences Inc. (Nasdaq: APRI) develops treatments in the areas of urology and rheumatology. Its lead product, Vitaros, is a topically applied cream for the treatment of erectile dysfunction (ED).

Hot Stocks To Buy For 2018: Harmony Gold Mining Company Limited(HMY)

Advisors’ Opinion:

  • [By Alex McGuire]

    This list shows the top-performing gold stocks this month, which we’ll be watching in September 2017. While these stocks posted gains in August, we still aren’t recommending them. Instead, we’re going to show you Money Morning Resource Specialist Peter Krauth’s pick for the best gold stock to buy this year…

    Top Gold Stock Share Price August 2017 Gain
    Sibanye Gold Ltd. (NYSE ADR: SBGL) $6.35 +22.9%
    Iamgold Corp. (NYSE: IAG) $6.49 +20%
    Alamos Gold Inc. (NYSE: AGI) $8.17 +15.1%
    Franco Nevada Corp. (NYSE: FNV) $81.20 +11.6%
    Hudbay Minerals Inc. (NYSE: HBM) $8.70 +11.5%
    Gold Fields Ltd. (NYSE ADR: GFI) $4.42 +10.9%
    Randgold Resources Ltd. (Nasdaq ADR: GOLD) $101.90 +9.6%
    Harmony Gold Mining Co. (NYSE ADR: HMY) $1.97 +8.8%
    Agnico Eagle Mines Ltd. (NYSE: AEM) $50.60 +8.4%
    Yamana Gold Inc. (NYSE: AUY) $2.81 +7.9%

    Life-Changing Profits: This investing strategy has racked up 30 triple-digit wins so far this year – and 46 in the last 12 months. To learn how to get in position for the next one, click here now…

  • [By Lisa Levin]

    On Wednesday, basic materials shares surged by 0.6 percent. Top gainers in the sector included Harmony Gold Mining Co. (ADR) (NYSE: HMY) and Gold Fields Limited (ADR) (NYSE: GFI).

  • [By Lisa Levin]

    In trading on Friday, basic materials shares tumbled by 1.20 percent. Meanwhile, top losers in the sector included McEwen Mining Inc (NYSE: MUX), down 6 percent, and Harmony Gold Mining Co. (ADR) (NYSE: HMY), down 6 percent.

  • [By Lisa Levin] Gainers
    Red Robin Gourmet Burgers, Inc. (NASDAQ: RRGB) shares rose 18.4 percent to $68.65 in pre-market trading as the company reported upbeat results for its first quarter.
    Jack in the Box Inc. (NASDAQ: JACK) shares rose 9.5 percent to $111.60 in the pre-market trading session after the company posted better-than-expected earnings for its second quarter. The company also disclosed that it has retained Morgan Stanley to evaluate potential alternatives for Qdoba.
    Coherus Biosciences Inc (NASDAQ: CHRS) rose 9.8 percent to $24.20 in pre-market trading. Coherus BioSciences disclosed that it prevailed in ‘135 IPR decision.
    Qiwi PLC (NASDAQ: QIWI) rose 8.1 percent to $21.49 in pre-market trading after reporting strong quarterly results.
    Korea Electric Power Corporation (ADR) (NYSE: KEP) shares rose 7.9 percent to $20.00 in pre-market trading after dropping 4.33 percent on Tuesday
    Target Corporation (NYSE: TGT) shares rose 7.5 percent to $58.60 in pre-market trading after the company reported stronger-than-expected results for its first quarter.
    AngloGold Ashanti Limited (ADR) (NYSE: AU) rose 4.3 percent to $11.71 in pre-market trading after falling 0.09 percent on Tuesday.
    Colgate-Palmolive Company (NYSE: CL) rose 4.1 percent to $74.53 in pre-market trading after the NY Post reported that the company might be up for sale for $100 per share.
    Harmony Gold Mining Co. (ADR) (NYSE: HMY) rose 4 percent to $2.35 in pre-market trading after declining 1.74 percent on Tuesday.
    Core Laboratories N.V. (NYSE: CLB) rose 3.6 percent to $109.00 in pre-market trading after gaining 0.39 percent on Tuesday.
    Clovis Oncology Inc (NASDAQ: CLVS) rose 3.2 percent to $51.15 in pre-market trading. JP Morgan upgraded Clovis Oncology from Neutral to Overweight.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Hot Stocks To Buy For 2018: Neuralstem, Inc.(CUR)

Advisors’ Opinion:

  • [By William Romov]

    Last Wednesday (Dec. 6), the company received a patent for certain methods of production of its phase 2 antidepressant, AV-101.

    Penny Stock Current Share Price Dec. 4 – Dec. 8 Gain (as of Dec. 8)
    VistaGen Therapeutics Inc. (Nasdaq: VTGN) $1.80 135%
    FXCM Inc. (Nasdaq: GLBR) $1.12 124%
    Neuralstem Inc. (Nasdaq: CUR) $2.00 75.44%
    Ohr Pharmaceuticals Inc. (Nasdaq: OHRP) $1.49 75.29%
    ClearSign Combustion Corp. (Nasdaq: CLIR) $3.50 53.85%
    Astrotech Corp. (Nasdaq: ASTC) $4.21 51.99%
    Burcon NutraScience Corp. (Nasdaq: BUR) $0.72 44%
    LM Funding America Inc. (Nasdaq: LMFA) $3.72 42.53%
    Second Sight Medical Products Inc. (Nasdaq: EYES) $1.75 42.28%
    Globus Maritime Ltd. (Nasdaq: GLBS) $1.47 41.35%

    As a result, its share price shot up from $0.92 to $2.52 on Wednesday. The stock pulled back to $1.80 by the end of the week, for a total gain of 135% for the week.

  • [By Lisa Levin]

    Shares of Neuralstem, Inc. (NYSE: CUR) were down 29 percent to $1.75. Neuralstem reported the pricing of public offering of common stock and warrants.

Hot Stocks To Buy For 2018: CVD Equipment Corporation(CVV)

Advisors’ Opinion:

  • [By Jim Robertson]

    At the beginning of the week, our Under the Radar Moversnewsletter suggestedsmall cap industrial machinery stock CVD Equipment Corporation (NASDAQ: CVV) as a long/bullish trade:

  • [By Jim Robertson]

    On Wednesday, our Under the Radar Moversnewsletter suggested small cap materials and coatings stock CVD Equipment Corporation (NASDAQ: CVV) as a short/bearish trade:

Hot Stocks To Buy For 2018: The Kraft Heinz Company(KHC)

Advisors’ Opinion:

  • [By Paul Ausick]

    The Kraft Heinz Co. (NASDAQ: KHC) fell about 7% Friday to post a new 52-week low of $67.65 after closing at $72.71 on Thursday. The 52-week high is $97.77. Volume of about 12.8 million was more than three times the daily average. The food processing company reported poor earnings this morning and suggested that sales could get worse as competition increases.

  • [By Ben Levisohn]

    Kraft Heinz (KHC) soared to the top of the S&P 500 today after making a $143 billion bid for Unilever (UL).

    Getty Images

    Kraft Heinzgained 11% to $96.65 today, while the S&P 500 rose 0.2% to 2,351.16. Unilever jumped 14% to $48.53.

    Bernstein’s Ali Dibadj considers Kraft Heinz’s offer for Unilver:

    The initial offer, which was rejected, provided an +18% premium to Unilever’s share price, while deals across the space typically go for roughly ~30%. While we have always speculated that Kraft-Heinz might go after Unilever’s Food business, today marks an interesting development as it has chosen to pursue the entire business, which is roughly ~60% HPC and ~40% Food. Key categories include laundry detergent, deodorant, and shampoo in HPC and ice cream, sauces/spreads, and tea in Food. Unilever’s business also has broad global exposure. Some have suggested that KHC may spin off Unilever’s HPC business. However, we believe this is unlikely to happen initially, as it makes up the majority of the business (~60% sales and EBIT) and has a more attractive growth profile compared to Food.

    Kraft Heinz’s market capitalization rose to $117.7 billion today from $106.2 billion yesterday. It reported net income of $4.2 billion on sales of $26.5 billion in 2016.

  • [By Shanthi Rexaline]

    Kraft Foods, which has since then merged with Heinz to form Kraft Heinz Co (NASDAQ: KHC), had said in 2012 that SNAP made up one-sixth of its revenues.

  • [By Money Morning Staff Reports]

    Represented are Wells Fargo & Co. (NYSE: WFC), Coca-Cola Co. (NYSE: KO), and Kraft Heinz Co. (Nasdaq: KHC), just to name a few.

    The Berkshire portfolio has 34 dividend stocks in total; of those, eight yield dividend returns in excess of 3% annually, according to Buffett’s latest SEC 13F filing on Feb. 14, 2017.

Leave a Reply

Your email address will not be published. Required fields are marked *